Dual-acting stapled peptides target both HIV-1 entry and assembly
Hongtao Zhang(Chinese Academy of Sciences), Asim K. Debnath(University of Central Florida), Alan Cooper(Charles Sturt University), Xiaohe Tong, Daniel Scacalossi(New York Blood Center), Eric O. Freed(National Cancer Institute), Shawn Lee, Peter Y. Mercredi(Howard Hughes Medical Institute), Francesca Curreli(New York Blood Center), Pallavi Bhargava(Simulations Plus (United States)), Michael F. Summers(University of Maryland, Baltimore County), Mansi Mehta(Howard Hughes Medical Institute), Abdül Waheed(East Tennessee State University)
Cited by 49
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Magnetically Propelled Fish‐Like Nanoswimmers
|Small|2016|271